BACKGROUND AND AIMS: Nestin is considered to be a marker of stem/progenitor cells in different tissues. Nestin expression was also described in various tumors. In pancreatic ductal adenocarcinoma (PDAC), its role in cancer cell migration, invasion, and metastases has been suggested. The study aimed at examining the expression of nestin in PDAC, and to evaluate its clinicopathological correlations. METHODS: The expression of nestin was immunohistochemically examined in 117 PDAC resection specimens, analyzed, and correlated with clinico-pathological parameters including perineural invasion (PNI). Analysis of nestin expression in nerve fibers in tissues of chronic pancreatitis (CP) was added. RESULTS: Immunohistochemical analysis of nestin expression showed 79 nestin negative (67.5 %) and 38 nestin positive (32.5 %) PDACs. No significant correlations of nestin expression in tumor cells with the analyzed clinicopathological parameters were demonstrated. Tumor grade (p<0.001) and nodal status (p=0.009) proved to represent independent prognostic factors. PNI was identified in 94 PDAC (80.3 %), and did not correlate with nestin expression. Nestin immunostaining was displayed in nerve fibers of both CP and PDAC tissues. CONCLUSION: An intimate link of nestin to a biological process of pancreatic cancer was confirmed. The expression of nestin did not prove to be a valuable prognostic factor and an immunohistochemical assessment of nestin expression is not superior to conventional prognostic factors in PDAC. A correlation between nestin expression in tumor cells and PNI was not confirmed and expression of nestin in nerve fibers of both PDAC and CP tissues seems to reflect the process of neural remodeling responsible for pancreatic neuropathy.
BACKGROUND AND AIMS: Nestin is considered to be a marker of stem/progenitor cells in different tissues. Nestin expression was also described in various tumors. In pancreatic ductal adenocarcinoma (PDAC), its role in cancer cell migration, invasion, and metastases has been suggested. The study aimed at examining the expression of nestin in PDAC, and to evaluate its clinicopathological correlations. METHODS: The expression of nestin was immunohistochemically examined in 117 PDAC resection specimens, analyzed, and correlated with clinico-pathological parameters including perineural invasion (PNI). Analysis of nestin expression in nerve fibers in tissues of chronic pancreatitis (CP) was added. RESULTS: Immunohistochemical analysis of nestin expression showed 79 nestin negative (67.5 %) and 38 nestin positive (32.5 %) PDACs. No significant correlations of nestin expression in tumor cells with the analyzed clinicopathological parameters were demonstrated. Tumor grade (p<0.001) and nodal status (p=0.009) proved to represent independent prognostic factors. PNI was identified in 94 PDAC (80.3 %), and did not correlate with nestin expression. Nestin immunostaining was displayed in nerve fibers of both CP and PDAC tissues. CONCLUSION: An intimate link of nestin to a biological process of pancreatic cancer was confirmed. The expression of nestin did not prove to be a valuable prognostic factor and an immunohistochemical assessment of nestin expression is not superior to conventional prognostic factors in PDAC. A correlation between nestin expression in tumor cells and PNI was not confirmed and expression of nestin in nerve fibers of both PDAC and CP tissues seems to reflect the process of neural remodeling responsible for pancreatic neuropathy.
Authors: Jose M Pimiento; Dung-Tsa Chen; Barbara A Centeno; Ashley H Davis-Yadley; Kazim Husain; William J Fulp; Chen Wang; Anying Zhang; Mokenge P Malafa Journal: Pancreas Date: 2015-01 Impact factor: 3.327
Authors: Hana Nechutova; Petr Dite; Marketa Hermanova; Ivo Novotny; Arnost Martinek; Pavel Klvana; Bohumil Kianicka; Miroslav Soucek Journal: Wien Med Wochenschr Date: 2014-03-12
Authors: Jan Skoda; Marketa Hermanova; Tomas Loja; Pavel Nemec; Jakub Neradil; Petr Karasek; Renata Veselska Journal: PLoS One Date: 2016-07-14 Impact factor: 3.240
Authors: Rémy Nicolle; Yuna Blum; Pauline Duconseil; Charles Vanbrugghe; Nicolas Brandone; Flora Poizat; Julie Roques; Martin Bigonnet; Odile Gayet; Marion Rubis; Nabila Elarouci; Lucile Armenoult; Mira Ayadi; Aurélien de Reyniès; Marc Giovannini; Philippe Grandval; Stephane Garcia; Cindy Canivet; Jérôme Cros; Barbara Bournet; Louis Buscail; Vincent Moutardier; Marine Gilabert; Juan Iovanna; Nelson Dusetti Journal: EBioMedicine Date: 2020-07-03 Impact factor: 8.143
Authors: Wasfi Alrawashdeh; Richard Jones; Laurent Dumartin; Tomasz P Radon; Pedro R Cutillas; Roger M Feakins; Branko Dmitrovic; Ihsan Ekin Demir; Guralp O Ceyhan; Tatjana Crnogorac-Jurcevic Journal: Mol Oncol Date: 2019-03-05 Impact factor: 6.603
Authors: Xiuxiang Tan; Shivan Sivakumar; Jan Bednarsch; Georg Wiltberger; Jakob Nikolas Kather; Jan Niehues; Judith de Vos-Geelen; Liselot Valkenburg-van Iersel; Svetlana Kintsler; Anjali Roeth; Guangshan Hao; Sven Lang; Mariëlle E Coolsen; Marcel den Dulk; Merel R Aberle; Jarne Koolen; Nadine T Gaisa; Steven W M Olde Damink; Ulf P Neumann; Lara R Heij Journal: Oncogene Date: 2020-12-07 Impact factor: 9.867